Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Galectin-3, Cardiac Function, and Fibrosis.
Meijers WC, López-Andrés N, de Boer RA. Meijers WC, et al. Am J Pathol. 2016 Aug;186(8):2232-2234. doi: 10.1016/j.ajpath.2016.05.002. Epub 2016 Jul 20. Am J Pathol. 2016. PMID: 27461364
Serial galectin-3 and future cardiovascular disease in the general population.
van der Velde AR, Meijers WC, Ho JE, Brouwers FP, Rienstra M, Bakker SJ, Muller Kobold AC, van Veldhuisen DJ, van Gilst WH, van der Harst P, de Boer RA. van der Velde AR, et al. Among authors: meijers wc. Heart. 2016 Jul 15;102(14):1134-41. doi: 10.1136/heartjnl-2015-308975. Epub 2016 Apr 15. Heart. 2016. PMID: 27084804 Free PMC article.
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.
Suthahar N, Meijers WC, Silljé HHW, Ho JE, Liu FT, de Boer RA. Suthahar N, et al. Among authors: meijers wc. Theranostics. 2018 Jan 1;8(3):593-609. doi: 10.7150/thno.22196. eCollection 2018. Theranostics. 2018. PMID: 29344292 Free PMC article. Review.
Galectin-3 in Heart Failure: An Update of the Last 3 Years.
Gehlken C, Suthahar N, Meijers WC, de Boer RA. Gehlken C, et al. Among authors: meijers wc. Heart Fail Clin. 2018 Jan;14(1):75-92. doi: 10.1016/j.hfc.2017.08.009. Heart Fail Clin. 2018. PMID: 29153203 Review.
From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.
Suthahar N, Meijers WC, Silljé HHW, de Boer RA. Suthahar N, et al. Among authors: meijers wc. Curr Heart Fail Rep. 2017 Aug;14(4):235-250. doi: 10.1007/s11897-017-0343-y. Curr Heart Fail Rep. 2017. PMID: 28707261 Free PMC article. Review.
Exercise and heart failure: Improve your functional status and your biomarker profile.
Meijers WC, de Boer RA. Meijers WC, et al. Eur J Prev Cardiol. 2017 Sep;24(13):1358-1359. doi: 10.1177/2047487317714849. Epub 2017 Jun 20. Eur J Prev Cardiol. 2017. PMID: 28631932 No abstract available.
Biomarkers to identify and prevent new-onset heart failure in the community.
Meijers WC, de Boer RA, Ho JE. Meijers WC, et al. Eur J Heart Fail. 2016 Nov;18(11):1351-1352. doi: 10.1002/ejhf.636. Eur J Heart Fail. 2016. PMID: 27813301 No abstract available.
Variability of biomarkers in patients with chronic heart failure and healthy controls.
Meijers WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, Wu AH, Jaffe A, de Boer RA. Meijers WC, et al. Eur J Heart Fail. 2017 Mar;19(3):357-365. doi: 10.1002/ejhf.669. Epub 2016 Oct 21. Eur J Heart Fail. 2017. PMID: 27766733 Free PMC article.
ST2 and Galectin-3: Ready for Prime Time?
Meijers WC, van der Velde AR, de Boer RA. Meijers WC, et al. EJIFCC. 2016 Aug 1;27(3):238-52. eCollection 2016 Aug. EJIFCC. 2016. PMID: 27683537 Free PMC article.
HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A, Meijers WC, Schroten NF, Gansevoort RT, de Boer RA, Silljé HH. Piek A, et al. Among authors: meijers wc. J Card Fail. 2017 Jan;23(1):12-19. doi: 10.1016/j.cardfail.2016.05.002. Epub 2016 May 17. J Card Fail. 2017. PMID: 27224553
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback